ZimVie Analyst Ratings
Needham Reiterates Buy on ZimVie, Maintains $20 Price Target
ZimVie Analyst Ratings
Barclays Sticks to Their Sell Rating for ZimVie Inc (ZIMV)
ZimVie Analyst Ratings
Needham Sticks to Their Hold Rating for ZimVie Inc (ZIMV)
ZimVie Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: ZimVie Inc (ZIMV) and Merus (MRUS)
ZimVie Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), ZimVie Inc (ZIMV) and Veeva Systems (VEEV)
Needham Sticks to Its Hold Rating for ZimVie Inc (ZIMV)
ZimVie Inc (ZIMV) Gets a Hold From Needham
ZimVie Analyst Ratings
ZimVie Analyst Ratings
Needham Keeps Their Hold Rating on ZimVie Inc (ZIMV)
ZimVie Analyst Ratings
JP Morgan Maintains Neutral on ZimVie, Lowers Price Target to $10
Barclays Maintains Underweight on ZimVie, Raises Price Target to $11
ZimVie Analyst Ratings
Barclays Adjusts Price Target on ZimVie to $7 From $5, Keeps Underweight Rating